Hereditary Neuropathy - complex
Gene: HADHA
Patients with LCHAD are characterised with a MTP deficiency and present with variable phenotypes. LCHAD and MTP deficiency is associated with myopathy, recurrent rhabdomyolysis and axonal neuropathy. Typically these patients survive into adolescent and adulthood.
PMID: 8871579, 23868323, 33744096, 12838198, 36063482
Reported in LCHAD individuals with neuropathy however no genomic confirmation.
PMID: 36063482
Neuropathy is typically a long term complication in surviving individuals of LCHAD. And typically resembles axonal CMT.
Loss of function is the mechanism of disease - P.Glu510Gln - most common homozygous variant. Founder variant in the Kashubian ancestry.
Neuropathy phenotype can be explained by the functional and physical interaction of tri functional protein with the respiratory chain.Created: 13 Jul 2023, 5:56 a.m. | Last Modified: 13 Jul 2023, 5:56 a.m.
Panel Version: 0.169
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
LCHAD deficiency MIM#609016; Mitochondrial trifunctional protein deficiency MIM#609015
Publications
Gene: hadha has been classified as Green List (High Evidence).
Phenotypes for gene: HADHA were changed from Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency to LCHAD deficiency MIM#609016; Mitochondrial trifunctional protein deficiency MIM#609015
Publications for gene: HADHA were set to
Tag treatable tag was added to gene: HADHA.
gene: HADHA was added gene: HADHA was added to Hereditary Neuropathy - complex_RMH. Sources: Royal Melbourne Hospital,Expert Review Green Mode of inheritance for gene: HADHA was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: HADHA were set to Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency